Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications

Detalhes bibliográficos
Autor(a) principal: Pinto, Artur Daniel Moreira
Data de Publicação: 2011
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://repositorio.cespu.pt/handle/20.500.11816/222
http://hdl.handle.net/20.500.11816/222
Resumo: Poly(lactic acid) (PLA) has several applications in biomedicine (sutures, scaffolds, implants, drug micro/nanoencapsulation). This aliphatic polyester is prepared from lactic acid (therefore derived from 100 % renewable sources, e.g. corn or sugarcane), biodegradable, biocompatible and has a low cost. [1][2] In order to make this material more attractive to the mentioned applications, as a valid alternative to petrochemical plastics, some properties should be improved, namely mechanical resistance and gas permeability. [3] Graphene, the elementary structure of graphite, is an atomically thick sheet composed of sp2 carbon atoms arranged in a flat honeycomb structure, possesses remarkable mechanical strength (Young’s modulus = 1 TPa, tensile strength = 130 GPa), an extremely high surface area (theoretical limit: 2630 m2·g-1) and is impermeable to gases. Graphene oxide (GO) is similar to graphene, but presents several oxygen-containing functional groups (e.g. hydroxyls, epoxides, and carbonyls). The presence of these polar groups reduces the thermal stability of the nanomaterial, but may be important to promote interaction and compatibility with a particular polymer matrix. [4] [5] It has been shown in studies with mice that GO is biocompatible [6] up to blood concentrations of 10 mg·kg-1 [7]; since only small amounts of graphene oxide are needed to reinforce poly(lactic acid), these nanocomposites could be used in food/medicines protection materials [3] and biomedical technology. [8] Effective mechanical reinforcement of polymeric materials using very small wt. % of GO has been reported by several authors. Wang and co-workers, improved the Young´s modulus of chitosan by 51% and the tensile strength by 91% incorporating 1 wt. % GO [9]. An increase of about 75% in polypropylene’s Young´s modulus and yield strength was achieved at 0.42 wt. % GO loading by Song and co-workers. [10] Cao and co-workers increased Young´s modulus of PLA by 18 % with only 0.2 wt. % of reduced GO. [11] Graphene oxide and graphene had been reported as efficient drug carriers [12] [13]. PLA is also used for this purpose [14]; development of hybrid vehicles for drug targeting can take advantage of both materials properties and originate synergistic effects. [15] Also several graphene based biosensors are being developed [16], these sensors can be used, for example, to detect drug concentrations on target places. Recent studies show that graphene substractes promote adherence of human mesenchymal stromal cells and osteoblasts [17], which can lead to better performance on tissues recovery using scaffolds containing graphene and graphene oxide. Due to their great potential several approaches are under study for future applications of these nanomaterials in biomedical engineering and biotechnology. [18] In this work, nanocomposite poly(lactic acid) (PLA) thin films were produced incorporating small amounts (0.2 to 1 wt. %) of graphene oxide (GO) and graphene nanoplatelets (GNP). Films were prepared by solvent-casting. Mechanical properties were evaluated for plasticized (by residual solvent) and unplasticized films. Plasticized nanocomposite films presented yield strength and Young´s modulus about 100 % higher than pristine PLA. For unplasticized films improvements in tensile strength and Young´s modulus were about 15 % and 85 %, respectively. For both film conditions, a maximum in mechanical performance was identified for about 0.4 wt. % loadings of the two filler materials tested. Permeabilities towards O2 and N2 decreased respectively three and fourfold in films loaded with both GO or GNP. The glass transition temperature showed maximum increases, in relation to unloaded PLA films, of 5 ºC for 0.4 % GO, and 7 ºC for 0.4 % GNP, coinciding with the observed maximums in mechanical properties. The incorporation of GO and GNP on PLA at low loadings (0.4 wt. %), don´t affect cellular proliferation at the surface of the resultant nanocomposites. This allows GNP and GO dispersion on polymers in order to obtain high performance materials for biomedical applications. Future work will be focused on improving the synthesized materials mechanical and gas barrier performance by optimizing the surface oxidation level and using different manufacture processes. Other biological assays will be performed to assure composite biocompatibility and to characterize it´s “in vitro” and “in vivo” behavior.
id RCAP_a68c807875f4c939c0e0c3df41dcd715
oai_identifier_str oai:repositorio.cespu.pt:20.500.11816/222
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applicationshogh performance polylactic acidbiomedical applicationsPoly(lactic acid) (PLA) has several applications in biomedicine (sutures, scaffolds, implants, drug micro/nanoencapsulation). This aliphatic polyester is prepared from lactic acid (therefore derived from 100 % renewable sources, e.g. corn or sugarcane), biodegradable, biocompatible and has a low cost. [1][2] In order to make this material more attractive to the mentioned applications, as a valid alternative to petrochemical plastics, some properties should be improved, namely mechanical resistance and gas permeability. [3] Graphene, the elementary structure of graphite, is an atomically thick sheet composed of sp2 carbon atoms arranged in a flat honeycomb structure, possesses remarkable mechanical strength (Young’s modulus = 1 TPa, tensile strength = 130 GPa), an extremely high surface area (theoretical limit: 2630 m2·g-1) and is impermeable to gases. Graphene oxide (GO) is similar to graphene, but presents several oxygen-containing functional groups (e.g. hydroxyls, epoxides, and carbonyls). The presence of these polar groups reduces the thermal stability of the nanomaterial, but may be important to promote interaction and compatibility with a particular polymer matrix. [4] [5] It has been shown in studies with mice that GO is biocompatible [6] up to blood concentrations of 10 mg·kg-1 [7]; since only small amounts of graphene oxide are needed to reinforce poly(lactic acid), these nanocomposites could be used in food/medicines protection materials [3] and biomedical technology. [8] Effective mechanical reinforcement of polymeric materials using very small wt. % of GO has been reported by several authors. Wang and co-workers, improved the Young´s modulus of chitosan by 51% and the tensile strength by 91% incorporating 1 wt. % GO [9]. An increase of about 75% in polypropylene’s Young´s modulus and yield strength was achieved at 0.42 wt. % GO loading by Song and co-workers. [10] Cao and co-workers increased Young´s modulus of PLA by 18 % with only 0.2 wt. % of reduced GO. [11] Graphene oxide and graphene had been reported as efficient drug carriers [12] [13]. PLA is also used for this purpose [14]; development of hybrid vehicles for drug targeting can take advantage of both materials properties and originate synergistic effects. [15] Also several graphene based biosensors are being developed [16], these sensors can be used, for example, to detect drug concentrations on target places. Recent studies show that graphene substractes promote adherence of human mesenchymal stromal cells and osteoblasts [17], which can lead to better performance on tissues recovery using scaffolds containing graphene and graphene oxide. Due to their great potential several approaches are under study for future applications of these nanomaterials in biomedical engineering and biotechnology. [18] In this work, nanocomposite poly(lactic acid) (PLA) thin films were produced incorporating small amounts (0.2 to 1 wt. %) of graphene oxide (GO) and graphene nanoplatelets (GNP). Films were prepared by solvent-casting. Mechanical properties were evaluated for plasticized (by residual solvent) and unplasticized films. Plasticized nanocomposite films presented yield strength and Young´s modulus about 100 % higher than pristine PLA. For unplasticized films improvements in tensile strength and Young´s modulus were about 15 % and 85 %, respectively. For both film conditions, a maximum in mechanical performance was identified for about 0.4 wt. % loadings of the two filler materials tested. Permeabilities towards O2 and N2 decreased respectively three and fourfold in films loaded with both GO or GNP. The glass transition temperature showed maximum increases, in relation to unloaded PLA films, of 5 ºC for 0.4 % GO, and 7 ºC for 0.4 % GNP, coinciding with the observed maximums in mechanical properties. The incorporation of GO and GNP on PLA at low loadings (0.4 wt. %), don´t affect cellular proliferation at the surface of the resultant nanocomposites. This allows GNP and GO dispersion on polymers in order to obtain high performance materials for biomedical applications. Future work will be focused on improving the synthesized materials mechanical and gas barrier performance by optimizing the surface oxidation level and using different manufacture processes. Other biological assays will be performed to assure composite biocompatibility and to characterize it´s “in vitro” and “in vivo” behavior.2012-11-29T10:29:46Z2011-01-01T00:00:00Z2011info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfhttps://repositorio.cespu.pt/handle/20.500.11816/222http://hdl.handle.net/20.500.11816/222porPinto, Artur Daniel Moreirainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-05-31T13:59:19Zoai:repositorio.cespu.pt:20.500.11816/222Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:57:09.504925Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
title Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
spellingShingle Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
Pinto, Artur Daniel Moreira
hogh performance poly
lactic acid
biomedical applications
title_short Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
title_full Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
title_fullStr Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
title_full_unstemmed Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
title_sort Preparation and characterization of high-performance poly (lactic acid) nanocomposites for biomedical applications
author Pinto, Artur Daniel Moreira
author_facet Pinto, Artur Daniel Moreira
author_role author
dc.contributor.author.fl_str_mv Pinto, Artur Daniel Moreira
dc.subject.por.fl_str_mv hogh performance poly
lactic acid
biomedical applications
topic hogh performance poly
lactic acid
biomedical applications
description Poly(lactic acid) (PLA) has several applications in biomedicine (sutures, scaffolds, implants, drug micro/nanoencapsulation). This aliphatic polyester is prepared from lactic acid (therefore derived from 100 % renewable sources, e.g. corn or sugarcane), biodegradable, biocompatible and has a low cost. [1][2] In order to make this material more attractive to the mentioned applications, as a valid alternative to petrochemical plastics, some properties should be improved, namely mechanical resistance and gas permeability. [3] Graphene, the elementary structure of graphite, is an atomically thick sheet composed of sp2 carbon atoms arranged in a flat honeycomb structure, possesses remarkable mechanical strength (Young’s modulus = 1 TPa, tensile strength = 130 GPa), an extremely high surface area (theoretical limit: 2630 m2·g-1) and is impermeable to gases. Graphene oxide (GO) is similar to graphene, but presents several oxygen-containing functional groups (e.g. hydroxyls, epoxides, and carbonyls). The presence of these polar groups reduces the thermal stability of the nanomaterial, but may be important to promote interaction and compatibility with a particular polymer matrix. [4] [5] It has been shown in studies with mice that GO is biocompatible [6] up to blood concentrations of 10 mg·kg-1 [7]; since only small amounts of graphene oxide are needed to reinforce poly(lactic acid), these nanocomposites could be used in food/medicines protection materials [3] and biomedical technology. [8] Effective mechanical reinforcement of polymeric materials using very small wt. % of GO has been reported by several authors. Wang and co-workers, improved the Young´s modulus of chitosan by 51% and the tensile strength by 91% incorporating 1 wt. % GO [9]. An increase of about 75% in polypropylene’s Young´s modulus and yield strength was achieved at 0.42 wt. % GO loading by Song and co-workers. [10] Cao and co-workers increased Young´s modulus of PLA by 18 % with only 0.2 wt. % of reduced GO. [11] Graphene oxide and graphene had been reported as efficient drug carriers [12] [13]. PLA is also used for this purpose [14]; development of hybrid vehicles for drug targeting can take advantage of both materials properties and originate synergistic effects. [15] Also several graphene based biosensors are being developed [16], these sensors can be used, for example, to detect drug concentrations on target places. Recent studies show that graphene substractes promote adherence of human mesenchymal stromal cells and osteoblasts [17], which can lead to better performance on tissues recovery using scaffolds containing graphene and graphene oxide. Due to their great potential several approaches are under study for future applications of these nanomaterials in biomedical engineering and biotechnology. [18] In this work, nanocomposite poly(lactic acid) (PLA) thin films were produced incorporating small amounts (0.2 to 1 wt. %) of graphene oxide (GO) and graphene nanoplatelets (GNP). Films were prepared by solvent-casting. Mechanical properties were evaluated for plasticized (by residual solvent) and unplasticized films. Plasticized nanocomposite films presented yield strength and Young´s modulus about 100 % higher than pristine PLA. For unplasticized films improvements in tensile strength and Young´s modulus were about 15 % and 85 %, respectively. For both film conditions, a maximum in mechanical performance was identified for about 0.4 wt. % loadings of the two filler materials tested. Permeabilities towards O2 and N2 decreased respectively three and fourfold in films loaded with both GO or GNP. The glass transition temperature showed maximum increases, in relation to unloaded PLA films, of 5 ºC for 0.4 % GO, and 7 ºC for 0.4 % GNP, coinciding with the observed maximums in mechanical properties. The incorporation of GO and GNP on PLA at low loadings (0.4 wt. %), don´t affect cellular proliferation at the surface of the resultant nanocomposites. This allows GNP and GO dispersion on polymers in order to obtain high performance materials for biomedical applications. Future work will be focused on improving the synthesized materials mechanical and gas barrier performance by optimizing the surface oxidation level and using different manufacture processes. Other biological assays will be performed to assure composite biocompatibility and to characterize it´s “in vitro” and “in vivo” behavior.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01T00:00:00Z
2011
2012-11-29T10:29:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.cespu.pt/handle/20.500.11816/222
http://hdl.handle.net/20.500.11816/222
url https://repositorio.cespu.pt/handle/20.500.11816/222
http://hdl.handle.net/20.500.11816/222
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131645720133632